Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Select Bancorp, Inc.

12.3% sales growth and 3.42% return on equity

Select Bancorp, Inc. operates as the bank holding company for Select Bank & Trust Company that provides banking services to individuals and small to medium-sized businesses.

Select Bancorp, Inc.’s sales growth this year is expected to be 7% and 6.3% for next year.

Year-on-year quarterly revenue growth grew by 0.9%, now sitting on 48.17M for the twelve trailing months.

Select Bancorp, Inc.’s sales growth for the next quarter is 12.3%. The company’s growth estimates for the ongoing quarter and the next is a negative 18.8% and 166.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.42%.

Volatility

Select Bancorp, Inc.’s last day, last week, and last month’s average volatility was 5.01%, 0.23%, and 0.34%, respectively.

Select Bancorp, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.79%, 6.77%, and 3.94%, respectively.

Select Bancorp, Inc.’s Stock Yearly Top and Bottom Value

Select Bancorp, Inc.’s stock is valued at $10.07 at 19:22 EST, way under its 52-week high of $11.91 and way higher than its 52-week low of $5.98.

Select Bancorp, Inc.’s Moving Average

Select Bancorp, Inc.’s value is above its 50-day moving average of $9.68 and way above its 200-day moving average of $8.34.

2. Nu Skin Enterprises, Inc.

25.4% sales growth and 18.89% return on equity

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide.

Nu Skin Enterprises, Inc.’s sales growth this year is anticipated to be 6.6% and 10.7% for next year.

Year-on-year quarterly revenue growth grew by 19.2%, now sitting on 2.42B for the twelve trailing months.

Nu Skin Enterprises, Inc.’s sales growth for the next quarter is 25.4%. The company’s growth estimates for the current quarter and the next is 63.9% and 105.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.89%.

Volatility

Nu Skin Enterprises, Inc.’s last day, last week, and last month’s average volatility was 2.32%, 1.36%, and 0.59%, respectively.

Nu Skin Enterprises, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.84%, 3.03%, and 2.96%, respectively.

Nu Skin Enterprises, Inc.’s Stock Yearly Top and Bottom Value

Nu Skin Enterprises, Inc.’s stock is valued at $59.04 at 19:22 EST, under its 52-week high of $59.71 and way higher than its 52-week low of $12.31.

Nu Skin Enterprises, Inc.’s Moving Average

Nu Skin Enterprises, Inc.’s worth is above its 50-day moving average of $54.03 and way above its 200-day moving average of $50.69.

3. Genmab A/S

50.9% sales growth and 36.46% return on equity

Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark.

Genmab A/S’s sales growth this year is anticipated to be 102.3% and a negative 20.7% for next year.

Year-on-year quarterly revenue growth grew by 65.8%, now sitting on N/A for the twelve trailing months.

Genmab A/S’s sales growth for the next quarter is 50.9%. The company’s growth estimates for the ongoing quarter and the next is a negative 64.2% and 30%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.46%.

Volatility

Genmab A/S’s last day, last week, and last month’s average volatility was 4.13%, 1.25%, and 0.44%, respectively.

Genmab A/S’s last day, last week, and last month’s high and low average amplitude percentage was 3.30%, 1.98%, and 1.80%, respectively.

Genmab A/S’s Stock Yearly Top and Bottom Value

Genmab A/S’s stock is valued at $42.83 at 19:22 EST, way below its 52-week low of $16.24.

Genmab A/S’s Moving Average

Genmab A/S’s value is above its 50-day moving average of $39.36 and way higher than its 200-day moving average of $36.95.

4. Brown & Brown, Inc.

6.7% sales growth and 13.1% return on equity

Brown & Brown, Inc. markets and sells insurance products and services in the United States, England, Canada, Bermuda, and the Cayman Islands.

Brown & Brown, Inc.’s sales growth this year is expected to be 8.5% and 7.3% for next year.

Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 2.54B for the twelve trailing months.

Brown & Brown, Inc.’s sales growth for the next quarter is 6.7%. The company’s growth estimates for the ongoing quarter and the next is 3.6% and 5.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.1%.

Volatility

Brown & Brown, Inc.’s last day, last week, and last month’s average volatility was a positive 1.20%, a negative 0.74%, and a negative 0.03%, respectively.

Brown & Brown, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.39%, 1.85%, and 2.08%, respectively.

Brown & Brown, Inc.’s Stock Yearly Top and Bottom Value

Brown & Brown, Inc.’s stock is valued at $46.78 at 19:22 EST, under its 52-week high of $48.76 and way above its 52-week low of $30.70.

Brown & Brown, Inc.’s Moving Average

Brown & Brown, Inc.’s worth is higher than its 50-day moving average of $46.00 and above its 200-day moving average of $45.49.

5. Rollins, Inc.

5.6% sales growth and 28.62% return on equity

Rollins, Inc., through its subsidiaries, provides pest and termite control services to residential and commercial customers.

Rollins, Inc.’s sales growth this year is expected to be 6.9% and 6.3% for next year.

Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 2.13B for the twelve trailing months.

Rollins, Inc.’s sales growth for the next quarter is 5.6%. The company’s growth estimates for the current quarter and the next is 18.2% and 22.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.62%.

Volatility

Rollins, Inc.’s last day, last week, and last month’s average volatility was a positive 2.44%, a negative 1.95%, and a negative 0.31%, respectively.

Rollins, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.66%, 4.21%, and 3.21%, respectively.

Rollins, Inc.’s Stock Yearly Top and Bottom Value

Rollins, Inc.’s stock is valued at $37.38 at 19:22 EST, way under its 52-week high of $43.00 and way above its 52-week low of $20.48.

Rollins, Inc.’s Moving Average

Rollins, Inc.’s worth is below its 50-day moving average of $38.67 and higher than its 200-day moving average of $36.99.

LEAVE A REPLY

Please enter your comment!
Please enter your name here